Body Composition and Cancer Outcomes Research Webinar Series
The purpose of the Body Composition and Cancer Outcomes Research webinar series is to provide an opportunity for researchers and other interested individuals to share lessons learned, new methodologies, and new research integrating measures of body composition in cancer epidemiology research. This series is hosted by the Epidemiology and Genomics Research Program.
All interested individuals are invited to participate, however pre-registration is required. Each presentation will be about 30-40 minutes in length to allow for 20-30 minutes of discussion. Instructions for connecting to the webinars will be sent via e-mail to individuals who register.
Upcoming Topics and Speakers
Past Topics and Speakers
Sarcopenia and Cancer Survival: Findings, Gaps, and Future Research
3:00 p.m. to 4:00 p.m. ET
Dr. Caan presented an overview of the work to date on sarcopenia (loss of skeletal muscle mass and/or function) and cancer outcomes. She discussed methodological challenges and existing research gaps and identify future directions.
Previous Body Composition and Cancer Webinar Series
A previous series of webinars, hosted by Dr. Bette Caan of Kaiser Permanente Northern California Division of Research, was held from 2018-2020.
Andrew Dannenberg, M.D., M.P.H. - “Measurement of adipose inflammation and its relationship to body composition.”
Peggy Cawthon, Ph.D., M.P.H. - “The new sarcopenia definition and outcomes consortium definitions of sarcopenia in aging: How can we adapt them to be used for cancer patients?”
Michael Rosenthal, M.D., Ph.D. - “Automated measurement of body composition in cancer patients: a radiologist perspective on integrating into clinical care.”
Kristin Campbell, Ph.D. - “Maintaining muscle health with exercise in cancer survivors: when and how to intervene.”
Jose Garcia, Ph.D. - “The biology of muscle loss in cancer and current therapeutic trials for the treatment of muscle loss.”
Patrick Bradshaw, Ph.D. - “Optimal stratification cutpoints for definition of sarcopenia and other body composition measures: When is it appropriate and when is it not?”
Maria Cristina Gonzalez, M.D., Ph.D. - “The use of bioelectrical impedance analysis (and phase angle) in cancer research.”
Stewart Wang, M.D., Ph.D. - “Normative values for body composition from multiple non-cancer populations.”
Carla Prado, Ph.D. - “Building muscle mass with targeted nutrition supplementation.”
Karteek Popuri, Ph.D. - “Automatic image segmentation for Body Composition Analysis”
Bill Evans, Ph.D. - “Use of D3-creatine dilution to measure muscle mass”
Brian Wolpin, M.D. - “Altered systemic metabolism as a marker of early pancreatic cancer”
Steven Heymsfield, M.D. - “11th International SCWD conference on cachexia, sarcopenia and muscle wasting”
Marina Mourtzakis, Ph.D. - “Methodological considerations for measuring muscle and fat quantity and quality using computed tomography and ultrasound.”
Vickie Baracos, Ph.D. - “Chemotoxicity in cancer: the sarcopenic obese patient.”